Effect of F2695 on Functional Recovery After Ischemic Stroke

Clinical trial NCT01639014 · COMPLETED

Trial details

NCT number: NCT01639014
Sponsor: Pierre Fabre Medicament
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ischemic Stroke

Start date: 2012-07-01
Primary completion: 2015-02-01
Enrollment: 532

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.